177 related articles for article (PubMed ID: 26318036)
21. CSN6 drives carcinogenesis by positively regulating Myc stability.
Chen J; Shin JH; Zhao R; Phan L; Wang H; Xue Y; Post SM; Ho Choi H; Chen JS; Wang E; Zhou Z; Tseng C; Gully C; Velazquez-Torres G; Fuentes-Mattei E; Yeung G; Qiao Y; Chou PC; Su CH; Hsieh YC; Hsu SL; Ohshiro K; Shaikenov T; Wang H; Yeung SC; Lee MH
Nat Commun; 2014 Nov; 5():5384. PubMed ID: 25395170
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis.
Oei AL; van Leeuwen CM; ten Cate R; Rodermond HM; Buist MR; Stalpers LJ; Crezee J; Kok HP; Medema JP; Franken NA
Cancer Res; 2015 Dec; 75(23):5120-9. PubMed ID: 26573798
[TBL] [Abstract][Full Text] [Related]
23. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.
Brimer N; Lyons C; Vande Pol SB
Virology; 2007 Feb; 358(2):303-10. PubMed ID: 17023019
[TBL] [Abstract][Full Text] [Related]
24. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53.
Xue Y; Chen J; Choi HH; Phan L; Chou PC; Zhao R; Yang H; Santiago J; Liu M; Yeung GE; Yeung SC; Lee MH
Cell Cycle; 2012 Nov; 11(22):4181-90. PubMed ID: 23095642
[TBL] [Abstract][Full Text] [Related]
25. Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex.
Sailer C; Offensperger F; Julier A; Kammer KM; Walker-Gray R; Gold MG; Scheffner M; Stengel F
Nat Commun; 2018 Oct; 9(1):4441. PubMed ID: 30361475
[TBL] [Abstract][Full Text] [Related]
26. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells.
Beer-Romero P; Glass S; Rolfe M
Oncogene; 1997 Feb; 14(5):595-602. PubMed ID: 9053858
[TBL] [Abstract][Full Text] [Related]
27. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
[TBL] [Abstract][Full Text] [Related]
28. An in silico appraisal of azoic and disulphide derivatives for anticancer activity against HPV E6 oncoprotein to medicate cervical cancer.
Choudhury AD; Choudhury MD; Chetia P; Chowdhury A; Talukdar AD
Comb Chem High Throughput Screen; 2014 Jan; 17(1):38-46. PubMed ID: 24164050
[TBL] [Abstract][Full Text] [Related]
29. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
30. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
31. HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells.
Hu Y; Ye F; Lu W; Hong D; Wan X; Xie X
Cancer Invest; 2009 Mar; 27(3):298-306. PubMed ID: 19194825
[TBL] [Abstract][Full Text] [Related]
32. The role of TP53 in Cervical carcinogenesis.
Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
[TBL] [Abstract][Full Text] [Related]
33. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
Tomaić V; Pim D; Banks L
Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.
Mao Z; Chen C; Pei DS
Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513
[TBL] [Abstract][Full Text] [Related]
35. HPV E6, E6AP and cervical cancer.
Beaudenon S; Huibregtse JM
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S4. PubMed ID: 19007434
[TBL] [Abstract][Full Text] [Related]
36. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential.
Elbel M; Carl S; Spaderna S; Iftner T
Virology; 1997 Dec; 239(1):132-49. PubMed ID: 9426453
[TBL] [Abstract][Full Text] [Related]
37. Loss of the E6AP Ubiquitin Ligase Induces p53-Dependent Phosphorylation of Human Papillomavirus 18 E6 in Cells Derived from Cervical Cancer.
Vats A; Skrabar N; Del Sal G; Banks L
J Virol; 2022 Mar; 96(6):e0150321. PubMed ID: 35044207
[TBL] [Abstract][Full Text] [Related]
38. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
Song L; Liu S; Zeng S; Zhang L; Li X
Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
[TBL] [Abstract][Full Text] [Related]
39. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.
Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y
Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802
[TBL] [Abstract][Full Text] [Related]
40. The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells.
Wang Y; Xie Y; Sun B; Guo Y; Song L; Mohammednur DE; Zhao C
Infect Agent Cancer; 2021 Dec; 16(1):71. PubMed ID: 34952616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
